Browse hierarchy: [Gastroenterology, Urology (GU)](/submissions/GU) → [Subpart F — Therapeutic Devices](/submissions/GU/subpart-f%E2%80%94therapeutic-devices) → [21 CFR 876.5016](/submissions/GU/subpart-f%E2%80%94therapeutic-devices/876.5016) → QXH — Gallbladder Drainage Stent And Delivery System

# QXH · Gallbladder Drainage Stent And Delivery System

_Gastroenterology, Urology · 21 CFR 876.5016 · Class 2_

**Canonical URL:** https://fda.innolitics.com/submissions/GU/subpart-f%E2%80%94therapeutic-devices/QXH

## Overview

- **Product Code:** QXH
- **Device Name:** Gallbladder Drainage Stent And Delivery System
- **Regulation:** [21 CFR 876.5016](/submissions/GU/subpart-f%E2%80%94therapeutic-devices/876.5016)
- **Device Class:** 2
- **Review Panel:** [Gastroenterology, Urology](/submissions/GU)
- **Implant:** yes

## Identification

The AXIOS Stent and Electrocautery-Enhanced Delivery System is a prescription device intended to facilitate transgastric or transduodenal endoscopic drainage of the gallbladder in patients with acute cholecystitis who are at high risk for surgery. The system consists of a flexible, magnetic resonance conditional, fully covered, self-expanding, braided nitinol stent with two flanges and a silicone covering, preloaded into an electrocautery-enhanced delivery system with an integrated handle for positioning and deployment.

## Classification Rationale

Class II (special controls). The device is classified as Class II because general controls alone are insufficient to provide reasonable assurance of safety and effectiveness, and there is sufficient information to establish special controls to mitigate the risks to health.

## Special Controls

In combination with the general controls of the FD&C Act, the gallbladder drainage stent and delivery system is subject to the following special controls:

## Recent Cleared Devices (1 of 1)

| Record | Device Name | Applicant | Decision Date | Decision |
| --- | --- | --- | --- | --- |
| [DEN230019](https://fda.innolitics.com/submissions/GU/subpart-f%E2%80%94therapeutic-devices/QXH/DEN230019.md) | AXIOS Stent and Electrocautery-Enhanced Delivery System  (10mm x 10mm Stent); AXIOS Stent and Electrocautery-Enhanced Delivery System  (15mm x 10mm Stent) | Boston Scientific Corporation | Aug 18, 2023 | DENG |

## Top Applicants

- Boston Scientific Corporation — 1 clearance

---

**Source:** [https://fda.innolitics.com/submissions/GU/subpart-f%E2%80%94therapeutic-devices/QXH](https://fda.innolitics.com/submissions/GU/subpart-f%E2%80%94therapeutic-devices/QXH)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com